Effects of TNFα inhibitors on adiposity and other cardiovascular risk factors: implications for the cardiovascular prognosis in patients with rheumatoid arthritis.
Fiche publication
Date publication
avril 2015
Journal
Expert opinion on drug safety
Lien Pubmed
Résumé
Rheumatoid arthritis (RA) is a chronic inflammatory disease that is associated with increased cardiovascular (CV) morbidity and mortality. This increased CV burden is the result of an enhanced prevalence of traditional CV risk factors, the effects of treatments given for RA but also systemic inflammation. In this setting, the control of inflammation by the current therapeutic approach may improve the overall CV prognosis of RA.
Mots clés
adiposity, atherogenic index, cardiovascular risk factors, lipids
Référence
Expert Opin Drug Saf. 2015 Apr;14(4):525-32